Depression News and Research

Latest Depression News and Research

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

25 Jun 2012

High suicide rates in specific regions or ethnic groups may be masked by falls in national rates for young men

In the second Series paper, Suicide in young men, a group of researchers led by Dr Alexandra Pitman of UCL (University College London) Mental Health Sciences Unit, UK, examine another under-investigated area of suicide research. After reviewing research published over the last decade, they found strikingly few studies distinguishing the factors which identify those young men (aged 19 – 30) at greatest risk of suicide.

25 Jun 2012

Self-harm and suicide in young people: the role of new media

In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford’s Centre for Suicide Research, and Professor Rory O’Connor of University of Stirling’s Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.

25 Jun 2012

Even moderate thyroid dysfunction during early pregnancy increases risk of serious complications

Even moderate thyroid dysfunction during early pregnancy significantly increases the risk of serious complications, underscoring the need for universal screening in the first trimester, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Drop in testosterone levels more likely to result from man's behavioral and health changes

A new study finds that a drop in testosterone levels over time is more likely to result from a man's behavioral and health changes than by aging. The study results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

ULH hopes to help women at risk of PPD through new policy

Although 13 percent of new mothers experience postpartum depression (PPD) in the first year after childbirth, few women recognize the symptoms and seldom discuss their feelings with a health care provider. University of Louisville Hospital (ULH) hopes to change this statistic through a new policy to guide hospital-based perinatal nurses in caring for women with risk of PPD.

23 Jun 2012

Plant compounds from South African daffodils show promise for depression

Scientists at the University of Copenhagen have previously documented that substances from the South African plant species Crinum and Cyrtanthus - akin to snowdrops and daffodils - have an effect on the mechanisms in the brain that are involved in depression.

23 Jun 2012

Sleep benefits some Parkinson's patients

Some Parkinson's patients report that their motor function is better upon awakening in the morning, which is contrary to what would be expected after a night without medication. This phenomenon, known as sleep benefit, has been studied but no consistent variables have been found and in the last decade there has been little new research.

22 Jun 2012

Teva launches Olanzapine and Fluoxetine Capsules for treatment of depression

Teva Pharmaceutical Industries Ltd. announced today the launch of Olanzapine and Fluoxetine Capsules USP 6 mg/25 mg, 12 mg/25 mg, 6 mg/50 mg, and 12 mg/50 mg, the Company's generic equivalent of Symbyax.

22 Jun 2012

IU receives CMS grant to expand Aging Brain Care model

A $7.8 million Health Care Innovation Award to Indiana University from the Centers for Medicare & Medicaid Services (CMS), will expand the Aging Brain Care model developed by researcher-clinicians from the IU Center for Aging Research and the Regenstrief Institute.

22 Jun 2012

CDSS best for assessing depression symptoms in schizophrenia

Results from a systematic review of published studies suggests that the Calgary Depression Scale for Schizophrenia is the most reliable and valid instrument for assessing depression symptoms in patients with schizophrenia.

21 Jun 2012

Study to test NAC and aspirin for people diagnosed with bipolar disorder

A commonly available pharmaceutical drug with anti-inflammatory properties and a nutritional supplement thought to have antioxidant effects are now being tested at The University of Texas Health Science Center at Houston (UTHealth) as add-on therapies for people diagnosed with bipolar disorder.

21 Jun 2012

Genetics play a significant role in determining side effects of opiates

Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University School of Medicine study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits.

21 Jun 2012

AHS scientific conference to focus on impact of traumatic brain injuries

The impact of traumatic injuries to the brain - whether sustained in combat or on the playing fields of America's schools - is a major topic for international migraine specialists the week of June 18 as they gather in Los Angeles for the 54th Annual Scientific Sessions of the American Headache Society. This is among many timely issues concerning headache, migraine, and brain injuries on the four-day agenda here which runs through Sunday morning, June 24.

21 Jun 2012

Depression News and Research

Latest Depression News and Research

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

High suicide rates in specific regions or ethnic groups may be masked by falls in national rates for young men

Self-harm and suicide in young people: the role of new media

Even moderate thyroid dysfunction during early pregnancy increases risk of serious complications

Drop in testosterone levels more likely to result from man's behavioral and health changes

ULH hopes to help women at risk of PPD through new policy

Plant compounds from South African daffodils show promise for depression

Sleep benefits some Parkinson's patients

Teva launches Olanzapine and Fluoxetine Capsules for treatment of depression

IU receives CMS grant to expand Aging Brain Care model

CDSS best for assessing depression symptoms in schizophrenia

Study to test NAC and aspirin for people diagnosed with bipolar disorder

Genetics play a significant role in determining side effects of opiates

AHS scientific conference to focus on impact of traumatic brain injuries

Some patients with Parkinson's experience sleep benefit

Mayo Clinic receives $60 million from CMMI to improve health care delivery

Omega-3 fatty acid supplements can reduce inflammation in overweight older adults

Sufficient cancer pain relief may mean frequent follow up

Teen mothers more likely to suffer abuse and postpartum depression than older moms

In Calif. and Mass., reforms proceeding even as court causes uncertainty

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Depression News and Research

Latest Depression News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in